Efficacy of Convalescent Plasma to Treat Long-Standing COVID-19 in Patients with B-Cell Depletion

The use of antivirals, corticosteroids, and IL-6 inhibitors has been recommended by the WHO to treat COVID-19. CP has also been considered for severe and critical cases. Clinical trials on CP have shown contradictory results, but an increasing number of patients, including immunocompromised ones, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomisti, Luca, Angelotti, Francesca, Lenzi, Mirco, Amadori, Francesco, Sarteschi, Giovanni, Porcu, Anna, Capria, Anna-Lisa, Bertacca, Gloria, Lombardi, Stefania, Bianchini, Guido, Vincenti, Antonella, Cesta, Novella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302885/
https://www.ncbi.nlm.nih.gov/pubmed/37374049
http://dx.doi.org/10.3390/life13061266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302885/
https://www.ncbi.nlm.nih.gov/pubmed/37374049
http://dx.doi.org/10.3390/life13061266

Ejemplares similares